ArticleIn silico pharmacology2025

In-silico-based lead optimization of hit compounds targeting mitotic kinesin Eg5 for cancer management.

Damilola S Bodun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.